2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-1H-1-pyrazolyl]-1-benzenesulfonamide (DRF-4367): an orally active COX-2 inhibitor identified through pharmacophoric modulation.
Sunil Kumar Singh , Saibaba Vobbalareddy , Srinivasa Rao Kalleda , Shaikh Abdul Rajjak
Organic and Biomolecular Chemistry 2 ( 17) 2442 -2450
13
2004
Assessment of oral bioavailability and preclinical pharmacokinetics of DRF-6196, a novel oxazolidinone analogue, in comparison to linezolid®
Ravikanth Bhamidipati , P Venkatesh , Prajakta V. Dravid , Prasad C. Narasimhulu
European Journal of Drug Metabolism and Pharmacokinetics 30 ( 3) 187 -193
2005
Pharmacological and pharmacokinetic evaluation of celecoxib prodrugs in rats.
Rao NVS Mamidi , Ramesh Mullangi , Jagannath Kota , Ravikanth Bhamidipati
Biopharmaceutics & Drug Disposition 23 ( 7) 273 -282
28
2002
Assessing the issue of instability due to Michael adduct formation in novel chemical entities possessing a carbon-carbon double bond during early drug development- applicability of common laboratory analytical protocols
Akshanth Reddy Polepally , Venkata V Pavan Kumar , Ravikanth Bhamidipati , Jagannath Kota
Biomedical Chromatography 22 ( 9) 960 -976
1
2008
Development and validation of an RP-HPLC method for the quantitation of odanacatib in rat and human plasma and its application to a pharmacokinetic study.
Anitha Police , Sandip Gurav , Vinay Dhiman , Mohd Zainuddin
Biomedical Chromatography 29 ( 11) 1664 -1669
2015
Prediction of clinical pharmacokinetic parameters of linezolid using animal data by allometric scaling: applicability for the development of novel oxazolidinones
R. K. Bhamidipati , P. V. Dravid , R. Mullangi , N. R. Srinivas
Xenobiotica 34 ( 6) 571 -579
12
2004
Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine A2A Receptor Antagonists and Their Biological Evaluation
Sujay Basu , Dinesh A Barawkar , Sachin Thorat , Yogesh D Shejul
Journal of Medicinal Chemistry 60 ( 2) 681 -694
9
2017
Antibiotics. Antiviral Drugs. Chemotherapeutics. Cytostatics-Validation of a Simple Bioanalytical Method for the Determination of DRF-6196, a Novel Oxazolidinone, in Mouse Plasma/Application
PV Dravid , RK Bhamidipati , R Mullangi , NR Srinivas
Arzneimittelforschung 55 ( 4) 239 -244
2005
Interspecies scaling of urinary excretory amounts of nine drugs belonging to different therapeutic areas with diverse chemical structures – accurate prediction of the human urinary excretory amounts
Ravi Kanth Bhamidipati , Ramesh Mullangi , Nuggehally R. Srinivas
Xenobiotica 47 ( 2) 112 -118
9
2017
HPLC method for determination of DRF-4367 in rat plasma: validation and its application to pharmacokinetics in Wistar rats.
Ramesh Mullangi , Raja Reddy Kallem , Ravi Kanth Bhamidipati , Rao N. V. S. Mamidi
Biomedical Chromatography 18 ( 8) 576 -580
2
2004
Sensitive method for the determination of rocilinostat in small volume mouse plasma by LC‐MS/MS and its application to a pharmacokinetic study in mice
Manish Gupta , Abhishek Dixit , V. C. Devaraj , Mohd Zainuddin
Biomedical Chromatography 30 ( 7) 1138 -1144
2
2016
Validation of an LC–MS/MS method for simultaneous detection of four HDAC inhibitors – belinostat, panobinostat, rocilinostat and vorinostat in mouse plasma and its application to a mouse pharmacokinetic study
Kalpesh Kumar Giri , P. S. Suresh , Syed Mohd Saim , Mohd Zainuddin
Biomedical Chromatography 31 ( 7)
3
2017
LC‐ESI‐MS/MS determination of 4‐methylpyrazole in dog plasma and its application to a pharmacokinetic study in dogs
Devaraj V Chandrasekhar , Ponnayyan Sulochana Suresh , Sreekanth Dittakavi , Rakesh A Hiremath
Biomedical Chromatography 32 ( 2)
1
2018
Retrospective and Prospective Human Intravenous and Oral Pharmacokinetic Projection of Dipeptidyl peptidase-IV Inhibitors Using Simple Allometric Principles - Case Studies of ABT-279, ABT-341, Alogliptin, Carmegliptin, Sitagliptin and Vildagliptin.
Ravindranath R Gilibili , Ravi Kanth Bhamidipati , Ramesh Mullangi , Nuggehally R Srinivas
Journal of Pharmacy and Pharmaceutical Sciences 18 ( 3) 434 -447
4
2015
Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase.
Sven Ruf , Mahanandeesha Siddappa Hallur , Nisha K Anchan , Indu N Swamy
Bioorganic & Medicinal Chemistry Letters 28 ( 5) 922 -925
11
2018
LC-MS/MS determination of tideglusib, a novel GSK-3β inhibitor in mice plasma and its application to a pharmacokinetic study in mice.
Neeraj Kumar Saini , P.S. Suresh , Mahalakhsmi Lella , Ravi Kanth Bhamidipati
Journal of Pharmaceutical and Biomedical Analysis 148 100 -107
4
2018
The human pharmacokinetics of odanacatib, a novel cathepsin K inhibitor, predicted by interspecies scaling: a retrospective analysis
Ravi Kanth Bhamidipati , Sandip Gurav , Anitha Police , Zainuddin Mohd
International Journal of Pharmacokinetics 2 ( 1) 47 -55
1
2017
Prediction of Human Pharmacokinetics of Ulixertinib, a Novel ERK1/2 Inhibitor from Mice, Rats, and Dogs Pharmacokinetics
Ponnayyan Sulochana Suresh , Ravi Kumar Jairam , Devaraj V Chandrasekhar , Anera Balakrishna Vinod
European Journal of Drug Metabolism and Pharmacokinetics 43 ( 4) 453 -460
2
2018
Area under the curve predictions of dalbavancin, a new lipoglycopeptide agent, using the end of intravenous infusion concentration data point by regression analyses such as linear, log-linear and power models.
Ravi Kanth Bhamidipati , Muzeeb Syed , Ramesh Mullangi , Nuggehally Srinivas
Xenobiotica 48 ( 2) 148 -156
1
2018
Validation of an LC–MS/MS Method for Simultaneous Detection of Five Selective KCNQ Channel Openers: ICA-27243, ML-213, PF-05020182, SF-0034 and Flupirtine in Mice Plasma and its Application to a Pharmacokinetic Study in Mice
Umesh Todmal , Suresh P. Sulochana , Mohd Zainuddin , Ravi Kanth Bhamidipati
Chromatographia 81 ( 3) 1 -12
1
2018